Skip to content

Leech Therapy for Hair Regrowth: A Clinical Study on Alopecia Areata in Adults (18-40 Years)

Randomized controlled clinical trial to evaluate the efficacy of Jalaukavacharana (Leech therapy) in the management of Indralupta w.s.r. to Alopecia areata. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081235
Enrollment
60
Registered
2025-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

None listed

Sponsors

Department of Shalya Tantra Dr VJD Gramin Ayurved Mahavidyalaya near Renuka Mata Mandir Patur Akola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients showing classical symptoms and sign of Indralupta as described in ayurvedic samhitas. 2. Bald patch present only on scalp. 3. Bald patch size upto 3cm. 4. Upto 4 bald patches. 5. Patients between the age of 18-40 years. 6. Patients will be selected who are willing to give informed consent and ready to comply with protocol. 7. Patients will be selected irrespective of gender, marital status, religion, educational and economical status.

Exclusion criteria

Exclusion criteria: 1. Patients are not willing. 2. Pregnant and lactating mothers. 3. Psychological disorders 4. Patients under the age of 18 and above 40years. 5. Patients with Bleeding disorders. 6. Patients with chronic Anemia. 7. Patients diagnosed with AIDS, HbsAg. 8. Bald patch present on body other than scalp. 9. Bald patch size more than 3cm. 10. Bald patch more than 4. 11. Patients having serious dermatological disorder of scalp

Design outcomes

Primary

MeasureTime frame
Symptoms like 1) Hairfall 2) Smooth patches on scalp will be decreased and control over Indralupta with reference to Alopecia areataTimepoint: 7 days, 15 days, 21 days after starting treatment

Secondary

MeasureTime frame
Decrease in Symptoms of IndraluptaTimepoint: 18 Months

Countries

India

Contacts

Public ContactDr Gayatri Dipak Mawale

Dr VJD Gramin Ayurved Mahavidyalaya Patur Akola

gayatriakola@gmail.com9850500860

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026